Skip to main content

Table 2 Resistance rate of different isolates from inpatient and outpatient settings

From: A retrospective analysis of the etiologic agents and antibiotic susceptibility pattern of uropathogens isolated in the Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan

Isolates Antibiotics
AMX CZO CRO NAL NOR SXT GEN NIT CTX VAN PEN ERY
IN OUT IN OUT IN OUT IN OUT IN OUT IN OUT IN OUT IN OUT IN OUT IN OUT IN OUT IN OUT
E. coli (n* = 91/594) 75.8 67.1 54.9 37.8 36.2 20.7 85.7 74.9 51.6 37.7 62.6 54.2 19.7 15.4 4.3 2.6 31.8 18.1
K. pneumonia (n* = 6/30) 66.6 30 66.6 10 33.3 20 16.6 13.3 50 26.6 50 3.3 16.6 10 50 10
Enterococcus spp. (n* = 9/14) 55.5 14.2 33.3 50 0 14.2 0 7.1 0 0 100 57.1 88.8 57.1
S. saprophyticus (n* = 4/16) 25 0 0 6.2 0 6.2 25 12.5 25 0 25 0 75 62.5 0 0
Acinetobacter spp. (n* = 4/14) 50 35.7 100 64.2 25 7.1 25 14.2 25 7.1 50 14.2 75 78.5 25 7.1
Proteus spp. (n* = 4/19) 0 63.1 0 89.4 0 0 0 31.5 0 10.5 25 31.5 0 10.5 0 0
K. oxytoca (n* = 3/7) 0 28.5 0 100 0 42.8 0 57.1 0 42.8 0 28.5 0 28.5 0 0 0 42.8
Citrobacter spp. (n*=1/8) 0 100 0 87.5 0 25 0 12.5 0 12.5 0 12.5 0 12.5 0 12.5 0 25
S. aureus (n*=1/6) 0 33.3 0 0 100 83.3 0 16.6
Enterobacter spp. (n*=1/7) 0 71.4 0 71.4 0 14.2 0 14.2 0 14.2 0 0 0 28.5 0 14.2
  1. n* inpatient/outpatient, IN inpatient, OUT outpatient, AMX amoxicillin, CZO cefazolin, CRO ceftriaxone, NAL nalidixic acid, NOR norfloxacin, SXT cotrimoxazole, GEN gentamicin, NIT nitrofurantoin, CTX cefotaxime, VAN vancomycin, PEN penicillin, ERY erythromycin